Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.

Moahad S Dar,Christoph Wanner,Nikolaus Marx,Anne Pernille Ofstad,Michaela Mattheus,Stefan Kaspers, Sami A Bég

Diabetes, obesity & metabolism（2023）

引用 0|浏览16

暂无评分

摘要

Applying the DSS across T2D clinical trial populations with different CV risk revealed a significantly increased risk of ACM and CV death with higher DSS stage. The DSS may merit assessment in other T2D populations and evaluation of the impact of additional outcomes, such as heart failure, could also be worthwhile.

查看译文

关键词

antidiabetic drug,cardiovascular disease,diabetes complications,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要